Healthcare providers prescribe vandetanib (Caprelsa®) for certain types of thyroid cancer -- in particular, this medication is used for medullary thyroid cancer that cannot be treated with surgery or that has spread beyond the thyroid. The medication comes in tablet form and is taken once a day. It is approved for adults only. At this time, no generic versions of this drug are being manufactured.
It's important to review vandetanib's safety information with your healthcare provider before beginning treatment. This drug may not be suitable for everyone, so make sure your healthcare provider is aware of any other medical conditions you have, such as kidney disease, an irregular heartbeat, or high blood pressure, or if you are taking any other types of medicine.
(For more information on this drug, click Vandetanib. Topics covered in this overview article include how it works, what to expect during treatment, what to do if you are pregnant or breastfeeding, and more.)
Written by/reviewed by: Arthur Schoenstadt, MD
Last reviewed by: ArthurSchoenstadt, MD
List of references (click here):
Caprelsa [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP;2011 April.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed October 25, 2011.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click